Cargando…
Clinical effect of Danshen decoction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials
BACKGROUND: The incidence of heart failure (HF) is increasing year by year, posing a great threat to human health. Although pharmacotherapy has been able to significantly prolong patient survival, pharmacotherapy for HF still has limitations due to its complex pathogenesis and considerable individua...
Autores principales: | Li, Ziyi, Liu, Mengnan, Chen, Mingtai, Luo, Gang, Wu, Jiao, Mazhar, Maryam, Yang, Fang, Zheng, Yu, Wu, Hao, Wu, Qibiao, Yang, Sijin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162557/ https://www.ncbi.nlm.nih.gov/pubmed/37146072 http://dx.doi.org/10.1371/journal.pone.0284877 |
Ejemplares similares
-
Danshen decoction in the treatment of heart failure: A systematic review and meta-analysis protocol of randomized controlled trials
por: Liu, Mengnan, et al.
Publicado: (2022) -
Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy
por: Liu, Mengnan, et al.
Publicado: (2022) -
Danshen Decoction in the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis Protocol of Randomized Controlled Trials
por: Liu, Mengnan, et al.
Publicado: (2022) -
Zhilong Huoxue Tongyu capsule inhibits rabbit model of hyperlipidemia and atherosclerosis through NF-κB/NLRP3 signaling pathway
por: Liu, Mengnan, et al.
Publicado: (2023) -
Network Pharmacology and In Vitro Experimental Verification Reveal the Mechanism of the Hirudin in Suppressing Myocardial Hypertrophy
por: Liu, Mengnan, et al.
Publicado: (2022)